About AstraZeneca China
AstraZeneca China is a company based in China. It operates as a Direct-to-Consumer (D2C). AstraZeneca China offers products and services including Tezspire and Weiliri. AstraZeneca China operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AstraZeneca China
AstraZeneca China offers a comprehensive portfolio of products and services, including Tezspire and Weiliri.
Tezspire is used for chronic sinusitis treatment.
Weiliri is offered for rare disease treatment.
Funding Insights of AstraZeneca China
Detailed funding history for AstraZeneca China
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AstraZeneca China
Investment portfolio details for AstraZeneca China
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AstraZeneca China
Detailed financials for AstraZeneca China
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Astrazeneca China Comparisons
Peer comparison for AstraZeneca China
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AstraZeneca China
AstraZeneca China operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of AstraZeneca China
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Astrazeneca China
Complete news archive for AstraZeneca China
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AstraZeneca China
AstraZeneca China is headquartered in China.
AstraZeneca China is involved in the development and distribution of pharmaceutical products. Focus is placed on key disease areas such as cardiovascular, kidney, and metabolic disorders, oncology, respiratory and immunology, digestive health, and rare diseases. Innovative solutions are provided through research and development, commercial strategies, and operational advancements. The company operates within the healthcare sector, contributing to patient care and treatment options across China.
AstraZeneca China's top competitors include Merck, Roivant Sciences and AbbVie.
AstraZeneca China offers Tezspire and Weiliri.